These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26224)

  • 21. Psychological medicine. Schizophrenia and related paranoid psychoses.
    Kennedy PF
    Br Med J; 1975 May; 2(5965):257-60. PubMed ID: 236808
    [No Abstract]   [Full Text] [Related]  

  • 22. [A differential effect profile of neuroleptic therapy of acute schizophrenic patients? Results of a clinico-naturalistic study].
    Schmidt LG; Siemetzki H
    Nervenarzt; 1988 Dec; 59(12):721-6. PubMed ID: 2905770
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness of ECT in Management of Depression in patients with schizophrenia: An Open Labelled Study.
    Grover S; Shouan A; Chakrabarti S; Sahoo S; Mehra A
    Schizophr Res; 2020 Aug; 222():530-531. PubMed ID: 32513545
    [No Abstract]   [Full Text] [Related]  

  • 24. Schizophrenia. A follow-up study of the results of five forms of treatment.
    May PR; Tuma AH; Dixon WJ; Yale C; Thiele DA; Kraude WH
    Arch Gen Psychiatry; 1981 Jul; 38(7):776-84. PubMed ID: 6113821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.
    Yoshida K; Higuchi H; Hishikawa Y
    Clin Neuropharmacol; 1998; 21(1):68-9. PubMed ID: 9579290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term treatment of schizophrenia in the community.
    Rollin HR
    Practitioner; 1982 Jul; 226(1369):1330-3. PubMed ID: 6125936
    [No Abstract]   [Full Text] [Related]  

  • 27. The intensity of anxiety in relation to the formation and amelioration of psychiatric symptoms.
    Lesse S
    Am J Psychother; 1973 Jul; 17(3):379-89. PubMed ID: 4146568
    [No Abstract]   [Full Text] [Related]  

  • 28. Symptoms of depression in schizophrenia.
    Murali T; Ravi Kumar S
    Indian J Med Res; 2008 Jun; 127(6):516-8. PubMed ID: 18765867
    [No Abstract]   [Full Text] [Related]  

  • 29. Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs.
    Mauri MC; Moliterno D; Rossattini M; Colasanti A
    Schizophr Res; 2008 Feb; 99(1-3):7-12. PubMed ID: 18055177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine monotherapy for late-onset vocal tics in a schizophrenic patient.
    Cheng WJ; Liu HC; Huang MC
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):700-1. PubMed ID: 18081638
    [No Abstract]   [Full Text] [Related]  

  • 31. Pipothiazine palmitate in the long-term treatment of schizophrenia.
    Aref MA; El-Guindy TA
    J Int Med Res; 1980; 8(4):293-4. PubMed ID: 6105981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerobic exercise for cognitive deficits in schizophrenia - The impact of frequency, duration, and fidelity with target training intensity.
    Kimhy D; Lauriola V; Bartels MN; Armstrong HF; Vakhrusheva J; Ballon JS; Sloan RP
    Schizophr Res; 2016 Apr; 172(1-3):213-5. PubMed ID: 26852401
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical issues related to depression in schizophrenia: an international survey of psychiatrists.
    Addington DD; Azorin JM; Falloon IR; Gerlach J; Hirsch SR; Siris SG
    Acta Psychiatr Scand; 2002 Mar; 105(3):189-95. PubMed ID: 11939972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of difficult to treat patients with schizophrenia, using non-drug therapies.
    Kuipers E
    Br J Psychiatry Suppl; 1996 Dec; (31):41-51. PubMed ID: 8968654
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment-resistant schizophrenia - biological treatments].
    Hasan A; Wobrock T
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):464-71; quiz 472. PubMed ID: 23939560
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: More on the treatment of delusional depressed patients.
    Ulett GA; Ziegler VE; Clayton PJ; Biggs JT
    Am J Psychiatry; 1975 Dec; 132(12):1332-3. PubMed ID: 916
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of high-dosage neuroleptic therapy and electroshock in the treatment of the acute phase of schizophrenia].
    Ungvári G; Bitter I; Czobor P; Vitrai J; Pethö B
    Psychiatr Neurol Med Psychol (Leipz); 1981 Aug; 33(8):458-63. PubMed ID: 6124987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open forum: effectiveness versus efficacy of second-generation antipsychotics: haloperidol without anticholinergics as a comparator.
    Rosenheck RA
    Psychiatr Serv; 2005 Jan; 56(1):85-92. PubMed ID: 15637198
    [No Abstract]   [Full Text] [Related]  

  • 40. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I; Levine S
    Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.